Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bryan G. Harder
Observed names:
B.G. Harder,
Bryan G Harder,
Bryan Harder,
Harder, Bryan
Observed institutions:
University of Arizona,
Tohoku University,
CTI BioPharma (United States),
Mayo Clinic in Arizona,
University of Pittsburgh Medical Center,
Arizona State University
show all 6
ORCID:
0009-0003-4912-3052
Observed ORCID:
0009-0003-4912-3052
OpenAlex ID:
A5062412277
p62 links autophagy and Nrf2 signaling
2015
·
Tao Jiang
, Bryan Harder
, et al.
·
Free Radical Biology and Medicine
·
639
Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention
2015
·
Bryan Harder
, Tao Jiang
, et al.
·
Biochemical Society Transactions
·
170
PDF
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
2018
·
Bryan G. Harder
, Mylan R. Blomquist
, et al.
·
Frontiers in Oncology
·
143
PDF
Brusatol overcomes chemoresistance through inhibition of protein translation
2016
·
Bryan Harder
, Wang Tian
, et al.
·
Molecular Carcinogenesis
·
136
Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?
2014
·
Tongde Wu
, Bryan G. Harder
, et al.
·
Molecular Carcinogenesis
·
118
Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle‐age period
2016
·
Mandi J. Corenblum
, Sneha Ray
, et al.
·
Aging Cell
·
100
PDF
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis
2023
·
Stephen T. Oh
, Ruben A. Mesa
, et al.
·
Blood Advances
·
83
PDF
Low-level arsenic causes proteotoxic stress and not oxidative stress
2018
·
Matthew Dodson
, Montserrat Rojo de la Vega
, et al.
·
Toxicology and Applied Pharmacology
·
57
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance
2018
·
David S Hersh
, Bryan G Harder
, et al.
·
Neuro-Oncology
·
43
Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
2019
·
Bryan G. Harder
, Sen Peng
, et al.
·
Molecular Medicine
·
40
PDF
Plant Extracts of the Family Lauraceae: A Potential Resource for Chemopreventive Agents that Activate the Nuclear Factor-Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway
2014
·
Tao Shen
, Xue-Mei Chen
, et al.
·
Planta Medica
·
32
Pharmacological Evidence for an Abstinence-Induced Switch in 5-HT1BReceptor Modulation of Cocaine Self-Administration and Cocaine-Seeking Behavior
2013
·
Nathan S. Pentkowski
, Bryan G. Harder
, et al.
·
ACS Chemical Neuroscience
·
23
Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene
2014
·
Mark J Canet
, Matthew D Merrell
, et al.
·
Drug Metabolism and Disposition
·
22
Arsenic Compromises Both p97 and Proteasome Functions
2017
·
Joseph Tillotson
, Christopher J. Zerio
, et al.
·
Chemical Research in Toxicology
·
17
Establishing a consensus definition of VEXAS flare for clinical research
2025
·
Lachelle D Weeks
, Danielle Hammond
, et al.
·
Lara D. Veeken
·
3
PDF
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome
2026
·
David B. Beck
, Maël Heiblig
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Plant Extracts of the Family Lauraceae: A Potential Resource for Chemopreventive Agents that Activate the Nuclear Factor-Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway
2014
·
Tao Shen
, Xue-Mei Chen
, et al.
·
Planta Medica
·
2
PDF
POS1124 Development of a Consensus Definition of VEXAS Flare for Use in Clinical Research
2025
·
L.D. Weeks
, D. Hammond
, et al.
·
Annals of the Rheumatic Diseases
·
1
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)
2026
·
Kevin Byram
, Heřman Mann
, et al.
·
Arthritis Care & Research
CSD 2473395: Experimental Crystal Structure Determination
2026
·
Yu, Kevin
, Stokes, Jamesa
, et al.
·
The Cambridge Structural Database
Csig-05. Pi3k Inhibitors Px-866 and Bez235 Differentially Modulate Autophagy in Gbm
2018
·
Bryan Harder
, Christopher Sereduk
, et al.
·
Neuro-Oncology
Abstract 4910: Development of an antagonist to the TWEAK-Fn14 ligand-receptor interaction with enhanced efficacy/potency in glioblastoma cells
2018
·
Bryan Harder
, Chris Sereduk
, et al.
·
Cancer Research
Molecular and Chemical Modulation of NRF2 for Disease Intervention
2017
·
Bryan Harder
·
UA Campus Repository (The University of Arizona)
Natural Product Compounds with a Dual Function: Nrf2 and Autophagy Induction
2014
·
Bryan Harder
, Tao Jiang
, et al.
·
Free Radical Biology and Medicine
Show more works
View as search
Works count:
26
Citation count:
1,631
H-index:
14
I10-index:
14
Year
Topic
Type
